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Summary 
The roles of the CD4 receptor and the src kinase p56 I'k were examined in the process of HIV- 
induced  apoptosis  of CD4 +  T  lymphocytes.  The  presence  of the  CD4  cytoplasmic  tail  was 
found to be essential in delivering an apoptotic signal, and interaction  of CD4 with p561ok po- 
tentiated HIV-induced apoptosis. Apoptosis, but not HIV replication,  was abrogated by delet- 
ing the NH2-terminal intracytoplasmic tail of CD4, or by mutating the two critical cysteines in 
this tail that are responsible for CD4-p56 Ick interaction.  Introduction  of p56 tck in C8166-45  or 
MT-2 cells, CD4 + T  cell lines deficient for this protein,  greatly increased HIV-induced apop- 
tosis and syncytium formation.  The ability of p56 l'k to deliver an apoptotic signal did not de- 
pend on its kinase function,  since a kinase-deficient mutant was as effective as its normal coun- 
terpart  in  inducing  apoptosis,  suggesting  that  p56 l~k may  act  as  an  adapter  to  anchor  other 
proteins to transduce  the death signal. 
H 
'IV-1  infection  of CD4 +  T  lymphocytes  in  cell  cul- 
~ture  induces  apoptotic  cell  death  in  the  absence  of 
HIV-specific antibody or immune response  (1, 2). Binding 
of glycoprotein  (gp)  120  to  CD4  on  already infected  cells 
appears to be a necessary step in the induction  of this form 
of apoptosis  (3).  This study was undertaken  to analyze ad- 
ditional  steps  in  HIV-induced  apoptosis  after  binding  of 
gp120 to the CD4 receptor. 
The membrane glycoprotein CD4 is the primary recep- 
tor for HIV-1  (4) but its normal function is to enhance an- 
tigen-mediated  activation  of T  cells  restricted  by  class  II 
molecules  of the  major histocompatibility  complex  (5-7). 
This function is initiated by CD4 aggregation and rendered 
possible  through  the  noncovalent  association  of the  cyto- 
plasmic tail  of the  CD4  protein with  p56 ~'~ (8,  9).  T  lym- 
phocytes  bearing  this  receptor  are  eliminated  throughout 
the course of HIV disease. The rate of the CD4 + T  cell de- 
pletion,  a hallmark of AIDS, remains the primary prognos- 
tic marker of disease progression. 
Both  direct  and  indirect  mechanisms  of cytopathology 
have been postulated to be responsible for CD4 + T  cell de- 
pletion  of AIDS.  These  include  syncytium formation  (10, 
11),  superinfection  (12),  gp120  binding  to  CD4  on unin- 
fected cells (13), antibody-dependent  cell cytotoxicity, kill- 
ing by cytotoxic CD8 + T  cell ofgpl20-coated cells, random 
V[3  T  lymphocyte  deletion  (14),  complement-mediated 
killing, and apoptosis (1, 2). 
Apoptosis is a normal cellular process culminating in the 
activation  of a  cellular  endonuclease  that  digests  chromo- 
somal DNA,  initially in large fragments (50-300  kbp), and 
ultimately, in small oligomers of 180 bp corresponding to a 
segment of DNA wrapped around a nucleosome and there- 
fore protected from enzymatic digestion.  Other phenotypic 
changes  are  also  manifested  during  apoptosis.  The  cell 
shrinks  and blebbing  occurs  to  facilitate ingestion  by pha- 
gocytic cells. Apoptosis is aimed at efficient removal of al- 
tered and unwanted  cells without  generating inflammatory 
responses and is part of an essential mechanism of cell attri- 
tion in developmental and regulatory processes (15,  16). 
CD4  signaling is a  complex process,  and how this func- 
tion  is  altered  during  HIV  infection  remains  unclear.  A 
number  of conflicting  reports  concerning  CD4  signaling 
have been presented,  gp120  binding  to the  CD4  receptor 
has  been  reported  to  inhibit  CD4-dependent  antigen  re- 
sponses  (17),  and  uncouples  TCR  signaling rendering  the 
cell anergic  (18).  Delivery of a signal after gp120-mediated 
CD4  multimerization  has been  reported  both  to  diminish 
or increase viral replication  (19, 20). 
The  roles  of the  CD4  receptor  and  p56 l~k in  triggering 
HIV-induced  apoptosis were investigated.  We have found 
that apoptosis occurred only in A2.01  T  cells in which  the 
wild-type  CD4  receptor  was  introduced.  In  contrast,  a 
truncated  form of CD4  or a  mutant  CD4  unable  to bind 
p56 tck were not susceptible to apoptosis despite being read- 
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tion was determined to be a requisite in delivering an apop- 
totic  signal,  and  introduction  and  overexpression  of p56 ;~k 
in  CD4 +  T  cells greatly increased  apoptosis  and  syncytium 
formation.  The ability of p56 vk to  deliver an apoptotic  sig- 
nal did not depend on kinase function,  as a kinase-deficient 
form of p56 Ick was as effective as its normal counterpart in in- 
ducing  apoptosis,  implying  that  other  molecules  are  in- 
volved in mediating the apoptotic signal. 
Materials  and Methods 
Cell Lines.  The  A2.01  and  HSB-2  parental  cell  lines  were 
obtained  from Dr.  rZafick-Pierre S6kaly  (Institut  de Recherches 
Cliniques de Montr4al, Montr4al,  Canada).  The CD4 wild-type, 
402 stop, and dicysteine mutant at positions 420 and 422 (C to A) 
have  been  previously described  (19).  MT-2  and  C8166-45  are 
HTLV-l-transformed CD4 + T  lymphoblastoid cell lines, which 
do not express p56 ;'k (21).  They were obtained from the National 
Institutes of Health AIDS Research and Reference Reagent Pro- 
gram. The CEM CD4 + T  lymphoblastoid cell line was obtained 
from Dr. Dennis Carson (University of California, San Diego, La 
Jolla). The wild-type CD4 gene and mutants were introduced in 
A2.01  and  HSB-2  using the retroviral vector MNC  stuffer and 
the amphotropic packaging cell line Damp  (22).  The p56 I~k gene 
(cloneHK28: Genbank accession number M36881) and phosphor- 
ylation-deficient  mutant  were  introduced  into  the  MT-2  and 
C8166-45  cell lines using the same methodology under the selec- 
tion  of gentamicin  (800  Dg/ml).  Two  MT-2  clones  expressing 
high levels of p56;'* were selected  (Nos.  10 and  11);  three were 
chosen from the C8166-45  cells (Nos. 7,  8, and 9),  as well as one 
representative  clone (No. p-mutant)  with substitution  of an ala- 
nine at position 273  (ATP-binding site)  for a lysine which ren- 
dered the protein incapable of phosphorylating itself (23). 
Viral Preparations.  High titer stocks of HIV-1LAI  (5  ￿  10  v tis- 
sue  culture infectious dose  [TClD]s0/ml)  were prepared  and  ti- 
tered using the end point dilution method of K~irber  (24).  High 
titer stocks were prepared  by inoculating CEM cells at a multi- 
plicity of infection (moi) 1 of 0.001  and growing the cells for 10 d. 
10 ml of this culture was added  to 400  ml of uninfected CEM 
(5  X  10 s cells/ml) and grown for 5-7  d  until abundant  syncytia 
were present. The cells were pelleted (300 g/lO min) resuspended 
in  1/100  of the initial vol for 8 h.  The supernatant  was clarified 
by centrifugation (800 g/lO rain). 
HIV-1 Infection.  The infection protocol was identical for each 
of the cell types used.  Briefly, 5-10  X  106 cells were inoculated 
with  HIV-1LM  at  moi  of 0.5  or  1  in  1  i511 culture  medium  in 
which  2  txg/ml  of polybrene  was  added  to  facilitate infection. 
The ceils were incubated for 3 h  at 37~  in 5% CO2 in air. The 
cells were  then  washed  once with  cold RPMI  1640  and  resus- 
pended at a density of 5  X  105 cells/ml in culture medium. Ali- 
quots of 1-2  ￿  106 cells were taken daily to perform the analyses. 
Detection  of Apoptosis-associated  Chromatin  Degradation  and  Cell 
Viability  by Flow Cytometry.  Cells  (~2  ￿  106) were washed  in 
PBS and resuspended in 30% ethanol and kept at 4~  The cells 
were stained with propidium iodide (PI)  as previously described 
(25,  26) with slight modifications. The cells were centrifuged and 
resuspended in PBS containing 0.1 mM EDTA(Na)2, R.Nase A at 
1Abbreviations used in this paper: moi, multiplicity of infection;  PI, propid- 
ium iodide. 
50  btg/ml  (50 U/mg),  and PI  (50  p~g/ml). The  cells were  then 
washed twice with PBS before analysis  by flow cytometry with a 
fluorescence-activated  cytometer  (Elite;  Coulter  Corp.,  Epics 
Div., Hialeah,  FL)  and the cell cycle was analyzed with doublet 
discrimination protocol. PI was excited using a 488-nm line of an 
argon laser and detected with a 620-700-nm long pass filter. This 
assay  has  an  SE  of +3%.  The  percentage  of apoptotic  cells was 
obtained for each time point by subtracting the percentage ofap- 
optotic cell death  in uninfected control cultures from the  HIV- 
infected culture.  Cell viability was determined by incubating 10 ~' 
cells  with  2  btM  of EthD1  (Molecular  Probes,  Inc.,  Eugene, 
OR),  which  stained  DNA if membrane  integrity was  not  pre- 
served. The cells were then fixed in 1% paraformaldehyde in PBS 
and analyzed within 3 h. 
Determination  of the Level of p56  t'k, p56  ;ok and  CD4 Association  by 
Immunoprecipitation  and Generation of  p5E 'k Autophosphorylation-d~- 
cient Mutant.  Determination of the level of p56 ;ok protein present 
in stably transduced  C8166-45  and MT-2 cells was carried out as 
follows.  106 cells were solubilized in SDS-PAGE electrophoresis 
Laemmli  buffer  under  reducing  conditions.  The  samples  were 
boiled  10  rain  and  subjected  to  electrophoresis  on  a  10%  SDS- 
acrylamide  gel.  The  gel  was  then  electroblotted  onto  a  nylon 
membrane.  Detection was  carried  out using a  combination  of a 
monoclonal  anti-p56 I'k mAb  (clone  3A5  at  a  1:3,000  dilution) 
(Santa  Cruz  Biotechnology,  Santa  Cruz,  CA)  and  an  affinity- 
purified peroxidase-conjugated sheep anti-mouse IgG2b antibody 
(1:5,000)  (The  Binding  Site,  Birmingham,  UK).  Immunoreac- 
tive bands were visualized using the ECL Detection System (Am- 
ersham Corp., Arlington Heights, IL) according to the manufac- 
turer's instructions. Similarly, the association ofp5ff  ck to CD4 was 
detemfined by solubilizing 2  X  10  v cells in 500 Ftl ofa lysis buffer 
consisting of 1% NP-40, 20 mM Hepes, pH 7.9,  150 mM NaC1, 
20 mM NaF,  1 mM Na3VO4, 1 mM Na4P207,  1 mM EDTA,  1 
mM EGTA,  10 b~g/ml aprotinin, and 10 Ixg/ml leupeptin for 45 
rain at 4~  The suspension was centrifuged at 14,000 rpm for 15 
min. The supernatant was then incubated at 4~  for 30 rain, with 
protein A-Sepharose (Pharmacia,  Uppsala, Sweden) and then 2 h 
with protein A-Sepharose previously coupled with anti-CD4 an- 
tibody (OKT4; Johnson and Johnson, Raritan,  NJ) (50 btl of pro- 
tein A-Sepharose  +  4  btg of OKT4 antibody overnight at 4~ 
The mixture was centrifuged at 10,000 rpm for 10 min and resol- 
ubilized directly in SDS sample buffer. The samples were electro- 
phoresed, blotted, and immunoreactive bands were visualized us- 
ing the ECL Detection System. 
An autophosphorylation-deficient p56 ;~k was generated by sub- 
stituting  the  lysine  residue  at  position  273  with  alanine  using 
PC1K  overlap extension procedure  (27).  Wild-type and  mutated 
p56 ;'k constructs  were  then  subcloned  in  the  eukaryotic  expres- 
sion  retroviral  vector  MNC  stuffer.  The  amphotropic  helper 
packaging cell line DAMP was transfected with the constructs by 
calcium  phosphate  coprecipitation.  The  resulting  recombinant 
amphotropic  retrovirus  particles  containing  the  human  p56  ;~k 
cDNA driven by the MuLV LTR and the neo gene driven by the 
SV40 promoter were used to stably infect C8166-45  and MT-2 
cells selected with 0.8-1  mg/ml of the antibiotic G418  (Gibco- 
BRL, Gaithersburg, MD). 
Autophosphorylation  of p56 ;'k  mediated  by  cross-linking  of 
cell surface CD4 was carried out as follows: C8166-45  cells (10  c') 
were incubated  with anti-CD4  Q428  antibody  (5  jxg/106  cells) 
before  incubation  with  goat anti-mouse  IgG  (20  Ftg/10  ~' cells). 
Cells were resuspended in lysis buffer (20 mM Tris-HCl, pH 8.0, 
150  mM NaC1,  2  mM EDTA,  1%  NP-40,  10% glycerol, 0.025 
mM p-nitrophenyl  guanidinobenzoate,  10  Ixg/ml aprotinin,  10 
40  HIV-induced Apoptosis Requires CD4 and p56 l~k Ixg/ml leupeptin,  1 mM sodium orthovanadate, and 10 mM so- 
dium  fluoride)  and  electrophoresed  on  a  10%  SDS-polyacryl- 
amide gel. Immunoreactive bands were visualized using the ECL 
Detection System. 
CD4 Staining andp24 ELISA.  For the quantitation of surface 
HIV-infected cells (106) were washed in PBS and resuspended  in 
200 Ixl ofPBS +  2% FBS. The anti-CD4 mAb OKT4 was added 
(20 txl) to the cells (except  secondary antibody used as a control 
for nonspecific binding) and kept at 4~  for 30 min for staining. 
The cells were then washed twice in PBS and resuspended  in 200 
txl of PBS  +  2% FBS to which 4  Ixl of goat anti-mouse IgG- 
FITC (Tago Inc., Burlingame,  CA) was added and kept at 4~ 
for 30 min. The cells were then washed in PBS and resuspended 
in 400 txl of 0.5% paraformaldehyde in PBS and kept in the dark 
at 4~  until analyzed by FACS  |  HIV p24 antigen was measured 
by an enzyme immunoassay as described by the manufacturer (Ab- 
bott Laboratories,  North Chicago, IL). 
Results 
Binding ofgpl20 to CD4 mediates apoptosis in HIV-1- 
infected  cells;  however,  the  intracytoplasmic  tail  of CD4 
has been shown to be dispensable for HIV replication.  The 
ability  of HIV-1  to  induce  apoptosis  was  investigated  in 
two  CD4 T  cell lines.  The wild-type full-length  CD4 re- 
ceptor  was  stably  introduced  into  both  the  A2.01  and 
HSB-2  CD4-negative  lymphoblastoid  T  cell  lines.  Stable 
transfectants  carrying a truncated  form of the  CD4 recep- 
tor,  with a  premature  stop  codon  at  position  402,  and  a 
mutated form with two point mutations replacing the two 
cysteine residues at positions 420 and 422 by alanines, were 
also generated (Fig.  1). The expression of all three forms of 
the  CD4  receptor  rendered  the  cell  fully  infectable  by 
HIV-1.  The  truncated  form  is  predicted  to  escape  CD4 
downregulation by viral  Nef protein  (28)  and presumably 
unable to deliver a signal through association with cytoplas- 
mic signaling proteins including p56 Ick. The dicysteine mu- 
tant  is  predicted  to  retain  all  the  capabilities  of the  wild- 
type CD4 receptor except the ability to bind p56 lck protein 
and transmit a signal via this pathway (29). 
The CD4-negative A2.01 parental cell line was uninfect- 
able, and did not undergo apoptosis despite being subjected 
to a high inoculum of HIV-ILa  i (moi: 1).  This is consistent 
with the notion that the CD4 receptor is essential for high 
efficiency  infection.  A  background  amount  of apoptosis 
(2.1%)  was observed and represents  the cell death of unin- 
fected cells occurring with in vitro cell culture conditions. 
The HIV p24 antigen values obtained 3 d after inoculation 
were very low and corresponded to residual inoculum per- 
sisting after washes  (9 ng/ml).  In contrast,  when the  CD4 
wild-type,  CD4  stop,  and  CD4  dicysteine  mutants  were 
inoculated, high levels of virus replication were observed as 
determined by HIV p24 antigen production (341,283, and 
286 ng/ml,  respectively).  Only the A2.01  expressing wild- 
type CD4 underwent apoptosis (24.9% at day 3 in this rep- 
resentative experiment.  The range was 22-34% in four ex- 
periments).  The  cells  expressing  CD4  stop  and  the  CD4 
dicysteine mutants  in which HIV replicated to high levels 
similar to the cells  expressing wild-type CD4, displayed lit- 
CD4 receptor 
402 
extracellular 
I  CD4 stop  cytoplasm 
=_ 
420 \  \  C04 mutant (C --~ A) 
\  \ 
Figure  1.  Schematic diagram of the intracytoplasmic tail of the CD4 
receptor. The  wild-type CD4  receptor was stably introduced in both 
A2.01 and HSB-2 lymphoblastoid T cell lines. A truncated form of the 
CD4 receptor with no cytoplasmic tail was generated by insertion of a 
stop codon at amino acid position 402. A dicysteine mutant was also gen- 
erated by replacing the two cysteines at amino acid positions 420 and 422 
by alanines rendering this molecule incapable of efficiently associating 
with the two cysteines (anfino acid positions 21 and 23) of  p56  l'k. 
tie  or  no  apoptosis  during  the  course  of the  experiment 
(Fig.  2  A).  A  small  amount  of apoptosis  was  initially  de- 
tected  in  CD4  dicysteine  mutant,  but  later,  at  day 7,  the 
percentage  of cell undergoing apoptosis returned  to back- 
ground level  (<5%).  Cell viability  as assessed  by flow cy- 
tometry was  >95%  for uninfected  cells,  >90%  for HIV- 
infected  cells,  except  A2.01  with  wild-type  CD4,  which 
was 55% at day 3. 
When  the  same  constructs  were  introduced  into  the 
CD4-negative  T  cell  line  HSB-2,  even  the  wild-type 
CD4-transfected  cell  line  failed  to  undergo  apoptosis  de- 
spite  high levels of viral  replication  equivalent  to that ob- 
tained  in  the  A2.0i  cells  (Fig.  2  B).  The  level  of surface 
CD4 expressed on both of these cell lines were similar (re- 
sults  not  shown)  and  could  not  account  for this  discrep- 
ancy.  However,  HSB-2  cells  have  a  mutated  form of the 
src  kinase  p56  Ick (substitution  V28L,  insertion  of QKP  at 
amino acid position 230, substitution A353V, and substitu- 
tion P447L) and despite a mutation at amino acid position 
28 (V to L), in proximity to two critical cysteines at amino 
acid residues 21  and 23, still bound the CD4 receptor (Fig. 
3). Furthermore HSB-2 p56 Ick has been reported to be cata- 
lytically activated and transforming in NIH 3T3 assays (30). 
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Figure 2.  Flow cytometric profiles of cell 
cycle analyses  of A2.01 cells (A) and HSB-2 
cells (B). Cell cycle analyses  of parental cell 
line,  wild-wpe  CD4,  CD4  stop  mutant 
cells, and CD4  dicysteine mutant cells ob- 
tained at day 3 with and without  inocula- 
tion  of  HIV-1LAI (moi: 0.5). Cell  cycle 
phases are indicated in  upper  right panel. 
The  proportion  of  cells  in  the  region 
marked APO represent cells with  sub-G1 
DNA  content  and were  considered apop- 
totic and quantified. The  difference in the 
percentage of apoptotic of cells present in 
HIV-infected cells vs control is indicated in 
the top right part of the HIV-l-inoculated 
group. Relative  cell number  is plotted on 
the  y-axis. 10,000 cells were  analyzed for 
each  condition.  A  representative  experi- 
ment is shown (n =  4). Note the extensive 
apoptosis occurring in A2.0I wild-type CD4. 
The constitutive activation of the p56 tck of HSB-2 cells may 
therefore preclude the induction ofapoptosis. 
Cell cycle analysis and generation of DNA profiles of in- 
fected A2.01 parental cells and those expressing each of the 
three forms of CD4  confirmed that only the  cells express- 
ing wild-type CD4 were susceptible to HIV-induced apop- 
tosis and  that  the  extent of apoptosis was  time  dependent 
and  correlated with  infection.  The  presence  of apoptotic 
cells increased with  time  and  anomalies  in  DNA  profiles 
were readily detectable, a constant feature being a diminu- 
tion  of the proportion of cells in the  G1  phase  of the  cell 
cycle, a concomitant increase in the fraction of cells present 
in G2/M,  and the appearance of cells with a sub-G1  DNA 
content  representing  apoptotic  cells  (Fig.  4,  A  and  B). 
These  cell  cycle  anomalies  were  previously  described  to 
occur in primary CD4 + T  lymphocytes and in the lympho- 
blastoid CD4 +  T  cell lines SupT1  (3).  This  effect was  not 
due  to inappropriate downregulation of the  CD4  receptor 
because  cells  expressing  wild-type  CD4  were  efficiently 
downregulated by HIV-1  (87% by day 3) compared to 68% 
for the CD4  stop and 95%  for the  CD4  dicysteine mutant 
at day 3. The CD4 stop mutant was downregulated slightly 
slower possibly due to the fact that Nes  the principal pro- 
tein responsible for the downregulation of the CD4 recep- 
Figure 3.  p56  vk and CD4 association  and immunoprecipitation. 2 ￿  107 
cells were  lysed and  the  supernatant reacted with  anti-CD4  antibody 
(OKT4) coupled to protein  A-Sepharose. 10 {*1 was loaded on a  12% 
SDS-PAGE gel. p56  Ick was detected as described  in Materials  and Methods. 
tor, requires the cytoplasmic tail of the receptor to exert its 
effect (28). Therefore, the downregulation obtained for the 
CD4 stop mutant may represent the contribution of recep- 
tor  endocytosis  due  to  virus  binding  or  alternatively  to 
more efficient trapping of the full-length CD4  receptor by 
gp160 in the endoplasmic reticulum. 
The  A2.01  cells expressing the  CD4  dicysteine mutant 
did  not  undergo  apoptosis.  This  mutant  differs  from  the 
wild-type CD4  only in its ability to bind p56 I'*. Moreover, 
HSB-2 cells did not undergo apoptosis despite the reintro- 
duction of the wild-type form of the CD4  receptor (Fig. 2 
/3)  suggesting  that  the  constitutively active  form  of p56  Ick 
present in  these cells may be responsible for the  resistance 
of these  cells to  apoptosis.  These  observations hinted  that 
p56 Ick may contribute in modulating HIV-induced apoptosis. 
To evaluate the effect of p56 tck in HIV-induced apoptosis, 
we stably introduced the wild-type gene and a kinase-inac- 
tive p56 lck mutant by transduction in  two  HTLV-l-trans- 
formed,  IL-2-independent,  CD4 +  T  cell lines,  C8166-45 
and MT-2.  These  two  CD4 +  T  cell lines  do  not  express 
p56/ok, but are highly susceptible to HIV-1  infection. Stable 
clones  were  generated  and  a  number  of high  expressing 
clones were  selected.  Reintroduction  of this  gene  had  no 
detectable  effect  on  the  growth  of these  cells  (results  not 
shown).  A  Western  blot  demonstrating  the  levels  of ex- 
pression  of p561ok protein  obtained  in  parental  C8166-45, 
C8166  cells transduced with the vector alone, in one of the 
high  expressor clones  (lck#7)  and  in  a  clone  expressing a 
kinase-deficient  form  of p56 l~k  is  presented  in  Fig.  5  A. 
Both  parental  and  vector-only C8166-45  (lanes  1  and  2, 
respectively) did not  express any detectable p56  tck in  con- 
trast to  clone lck#7  (lane 3)  and a  kinase-negative mutant 
(lane  4).  To  verify  the  phenotype  of the  kinase-inactive 
p56 I~k, the CD4 receptor of both C8166-45  cells transfected 
with wild-type p561ok (clone lck#7)  and the clone express- 
ing  the  kinase-negative  form  of p56  I~k were  cross-linked 
with  anti-CD4  antibodies.  This  type  of cross-linking will 
mediate,  within  5  rain,  a  potent  autophosphorylation  of 
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Figure 4.  Flow cytometric profiles of cell cycle analyses of 
A2.01 cells (A). Cell cycle analyses of  parental cell line, wild- 
type CD4, CD4 stop mutant cells,  and CD4 dicysteine mu- 
tant cells obtained daily for 3 d after infection with HIV-1L^  [ 
(moi: 0.5). The profiles of control cells at day 3 are also pre- 
sented. Relative cell number is plotted on the y-axis. 10,000 
cells  were  analyzed for each condition and a  representative 
experiment is shown. B provides the percentage of apoptosis 
present for each day as well as the percentage of CD4 down- 
regulation and amount of p24 antigen at day 3. 
p56  vk, which can be detected using an antiphosphotyrosine 
antibody in a Western blot.  Constitutive expression of the 
phosphorylated  form  of p561~k was  strong  in  cells  stably 
transduced  with  wild-type p56  I~k but was minimal in  cells 
carrying kinase-inactive form of p56  vk (Fig.  5 B, lanes  1 and 
3,  respectively).  Upon  cross-linking with  anti-CD4  anti- 
bodies only the wild-type p561Ck-expressing cell line showed 
an increase in  phosphorylated p56  lck (compare lanes  1 and 
2).  The autophosphorylation-deficient mutant of p56  I'k did 
not  generate  phosphorylated  p56  l'k  (lane  4).  Thus,  both 
wild-type p56  I~k and an autophosphorylation-deficient form 
of p56  tck can be stably introduced and expressed in C8166- 
45.  Similar results were  obtained with  the  MT-2  cell line 
(results  not shown). 
Upon HIV-1 infection,  the presence of either the wild- 
type  or  the  autophosphorylation-deficient  form  of p5ff  ck 
greatly exacerbated the cytopathic effects of the virus. Both 
HIV-induced apoptosis and syncytium formation appeared 
with  an  earlier  onset  and  greater  intensity  than  controls. 
The  cytopathic  effects also  seemed  to  correlate  with  the 
amount of p56  t'* expressed in the  cell lines.  DNA content 
profiles were obtained 3  d  after infection for both controls 
and HIV-infected cultures  of C8166-45,  C8166-45  trans- 
duced with the vector only, with wild-type p56  Ick (lck#7), 
or with an autophosphorylation-deficient mutant.  Despite 
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high levels of initial viral replication in all infected cells  as 
measured by p24  antigen  production,  only the  wild-type 
p561ok and the  autophosphorylation-deficient p56  Ick mutant 
showed  extensive aP0Ptosis  early in  the  infection process, 
as determined by the percentage of cells with sub-G1 DNA 
content (Fig.  6, A  and B). Levels of p24 antigen were actu- 
ally lower  in  both  Lck#7  and  the  autophosphorylation- 
deficient p5ff'* mutant at day 3 due to extensive cytopathic 
effects and loss  of HIV-l-producing cells.  This effect cor- 
related with the persistence of cell surface CD4 during the 
Figure  5.  Presence  of p56  t~k  and  verification  of kinase  activity.  (A) 
Western blot of C8166-45  (lane  I), vector only (lane 2),  lck#7  (lane 3), 
and kinase defective mutant (lane 4) (106 cells/condition) were solubilized 
directly in SDS-PAGE buffer and run on a 12% acrylamide gel. p56  tCk was 
revealed with an anti-p56/'k antibody and enhanced chenfiluminescence 
detection kit.  (214) Molecular weight marker in kilodaltons indicated on 
the left side of the panel. (B) Western blot of phosphorylated p56  t'~" as de- 
tected by a phosphotyrosine antibody. Clone lck#7 unstimulated (lane  1) 
and stimulated by cross-linking with anti-CD4 antibody (lane 2). Kinase- 
defective mutant unstimulated (lane 3) and cross-linked (lane 4). A 
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Figure 6.  Flow  cytometric profiles of cell cycle analyses of 
C8166-45 cells. (A) Cell cycle analyses obtained at day 3 of 
parental, vector control, lck#7,  and  autophosphorylation- 
negative mutant without  (control)  and  with  infection by 
HIV-1LA  I (moi: 0.5). 10,000 cells were used for each analysis 
and a representative experiment is shown. B provides the 
percentage of apoptosis and CD4 down-regulation present 
for each day as well as the amount of p24 antigen at day 3. 
course  of the  infection  (Fig.  6  B).  3  d  after  infection, 
C8166-45 cells transduced with the vector only had down- 
regulated its  CD4 receptors by 73% as opposed to 28% for 
wild-type p56 t'k and 34% for the autophosphorylation-defi- 
cient  p56 tck mutant.  Cells  stably  expressing  p56 Ick showed 
marked cytopathic effects due to HIV-1  infection and the 
rapid  appearance  of syncytia.  Only  6%  of  the  parental 
C8166-45  and  cells  transduced  with  the  vector  formed 
syncytia as assessed  by flow cytometric analysis where cells 
with a DNA content greater than 4n (aneuploid) would be 
considered to be a syncytium. It should be noted that syn- 
cytia  >60  p~M  in  diameter  would  be  excluded  from the 
analysis due to the presence of exclusion filters in the flow 
cytometer.  Syncytia were  seen in  15%  of wild-type p56  t'* 
and 17% of autophosphorylation-deficient p561ok cells  (rep- 
resentative  of three  independent  experiments).  Neverthe- 
less, the majority of the cells still died at the single cell level 
through  apoptosis.  The  extent  of cytopathic  effects  could 
readily be detected  (Fig.  7).  Balloon ceils could be seen as 
early as 16 h  after infection at an moi of 0.5 for both lck#7 
and the autophosphorylation mutant cell lines. 
Discussion 
HIV-1  infection  downregulates  the  surface  expression  of 
the CD4 receptor by at least two mechanisms. The nefgene 
product efficiently downregulates the expression of surface 
CD4 early in infection (28, 31).  The vpu  and the  env  gene 
products  act in  concert to  trap  the  CD4  molecule  in  the 
endoplasmic reticulum and facilitate its digestion to prevent 
its  expression on the cell surface (32, 33). Downregulation 
of CD4 might benefit the virus because the persistence  of 
high levels of CD4 expression on the surface of an infected 
cell would diminish continued virus replication.  If the cell 
44  HIV-induced Apoptosis Requires  CD4 and p56 lck Figure  7.  Effects of the introduction  of p56  I'* in  C8166-45  lympho- 
blastoid CD4 +  T  cells.  Photomicrographs taken  at  day 2  of uninfected 
cells  (A), HIV-inoculated clone lck#7  cells (B)  and HIV-inoculated lck 
autophosphorylation-negative mutant cells  (C). The presence ofsyncytia 
can readily be detected (arrows).  ￿ 
were to retain full CD4  expression, it might be more sus- 
ceptible to the deleterious consequences of superinfection, 
the induction  of anergy by gp120 binding to the receptor, 
syncytium formation, and, as indicated in the current stud- 
ies, apoptosis. In these studies, clear evidence was presented 
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indicating  that  the  cytoplasmic tail  of CD4  is required  to 
mediate  and  modulate  HIV-induced apoptosis.  Apoptosis 
provides a mechanism to abort continuing virus replication 
in a cell.  It is interesting to note that CD4 + T  cell lines that 
constitutively express low  CD4  levels can be made  to  be 
chronic producer lines of HIV-1 (Hut 78, for example) but 
not  CD4  +  T  lymphoblastoid  cell  lines  that  express  high 
levels of CD4, such as SupT1  and MT-4  (Corbeil, J., un- 
published observation; and 34). This evidence points to an 
important  role  for  downmodulation  of CD4  expression 
during HIV infection to enhance continuing vires replication. 
We  have previously generated  evidence that  the  initial 
entry of HIV-1 resulted in infection and viral replication in 
permissive cells but only subsequent signaling by gp120 to 
CD4 at the cell surface of these infected cells triggered apop- 
tosis.  We  have  demonstrated  that  inoculation  of SupT1 
cells  by HIV-1  (moi  =  1)  did not induce  apoptosis when 
AZT (10 IxM) was added 2 h earlier, suggesting that at least 
reverse  transcription  and  possibly the  production  of viral 
proteins had to occur to render the cells susceptible to apop- 
tosis.  In the  same setting,  the  addition  of the protease in- 
hibitor  saquinavir  could  not  block  apoptosis  even  when 
added 2 h  before inoculation.  In this case viral production 
is mostly unhampered but yields noninfectious virions. In- 
terestingly, adding dextran sulfate (10 Ixg/ml) at a concen- 
tration to exclude cell surface signaling and new infection, 
7 h after inoculation to allow the first part of the virus cycle 
to proceed, inhibited apoptosis completely despite the pro- 
duction of large amounts of virus. These studies thus sug- 
gest that a target cell had to be infected and then resignaled 
at the cell surface to undergo apoptosis (3). 
The present studies demonstrate that the apoptotic signal 
is delivered through  the  cytoplasmic tail  of CD4  and that 
further interaction with the src-related protein tyrosine ki- 
nase p56  t~k augments the extent ofapoptosis observed. CD4 
is physically associated with p56  J'k (29,  35). Cell surface en- 
gagement of CD4 leads to  enzymatically activation of the 
associated p56  Ick and the phosphorylation of T  cell proteins 
on tyrosine residues  (36).  In the context of HIV infection, 
p56  Ick is required  to prolong the presence  of CD4  on the 
cell  surface  (37)  permitting  the  delivery of the  apoptotic 
signal and to anchor other proteins to transduce the signal. 
Although Lck is not an absolute requirement for inducing 
apoptosis,  it  appears  to  have  some  kinase-independent 
modulatory role in  regulating apoptosis mediated through 
the  cytoplasmic tail  of CD4  because an  autophosphoryla- 
tion-negative  mutant  stably  introduced  in  C8166-45  in- 
duced levels of apoptosis similar to  wild-type p56  lck. This 
mutant cannot autophosphorylate because of a mutation at 
the ATP-binding site (aa273:  L to A). Additional evidence 
using the  wild-type CD4  HSB-2 T  cell line,  which  has a 
constitutively  activated  mutant  form  of p56  vk,  confirmed 
that disruption of this pathway abrogates HIV-induced ap- 
optosis,  implying that  constitutive  activation prevents the 
apoptotic  signal  triggered  by  HIV-1.  Alternatively,  the 
HSB-2 cells  may have mutated downstream effectors, en- 
abling  it  to  survive  constitutively active Lck,  which  may 
impact  on  the  HIV-induced  apoptosis.  Candidate  mole- cules to transmit the apoptotic signal through the CD4 sig- 
naling pathway would be ZAP-70 which has been reported 
to associate directly through the SH2 domain interaction of 
p56 vk  (38).  Alternatively, a  32-kD  GTP  protein  has  also 
been reported to associate directly with p56 Ick when p56 vk is 
bound to the CD4 receptor (39); this association may con- 
vey the message to  undergo  apoptosis. Another candidate 
molecule to  associate with  p56 t'k would be  Raf-l-related 
p110  which  serves  as  a  bridge  between  the  CD4-p56 I'~ 
complex  and  the  serine/threonine  kinase  pathways  of T 
cell activation (40, 41). 
A  mutational analysis of the SH2 domain and myristoy- 
lation of p56 Ick may reveal if the putative interactions men- 
tioned above require CD4  and p56  lck colocalization at the 
cytoplasmic membrane.  It should be noted that the subse- 
quent  interactions  of p56 tck with  ZAP-70,  p110  raf-1,  or 
p32-kD  proteins  have  not  been  demonstrated  in  HIV- 
infected  cells.  Defective  protein  tyrosine phosphorylation 
and altered levels of p56 i~k in CD4 +  T  cells obtained from 
HIV-l-infected patients have been reported however (42). 
Furthermore, HIV-1  may actually interfere with appropri- 
ate signal transduction through  the  CD4  signaling cascade 
and induce apoptosis. Interaction between the viral protein 
Nefwith the CD4 cytoplasmic tail may disrupt p56 Ick bind- 
ing (43)  or attachment of other cellular factors, resulting in 
inappropriate signaling and ultimately apoptosis. 
HIV-1 replication proceeds at extremely high rates in in- 
fected individuals (44, 45) and the quantity of virus present 
and the proportion of cells infected could account for the 
rate of depletion observed (46-49).  CD4 + T  cell depletion 
is certainly not due only to HIV-induced apoptosis; a sub- 
stantial contribution would  be  provided by  the  action  of 
cytotoxic T  cells in the background of cell death due to the 
general state of activation of the immune  system in HIV- 
infected individuals, which  has been  shown  to  contribute 
to apoptosis detected in lymph nodes (50).  It is interesting 
to  note  that  the prevention  of apoptosis in  HIV-infected 
cells would result in the production of more virus and gen- 
erate a state of chronic infection (51). Therefore, therapeu- 
tic  modalities  aimed  at  preventing  apoptosis,  which  is  a 
normal  physiological process,  as  suggested  recently  (52) 
should be viewed with  caution as such interventions may 
result in the production of more virus and possibly immor- 
talization of cells (lymphomas) which would not be benefi- 
cial to the host. 
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